Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Steven Friedel

Orthopaedic Surgery Red Bank, NJ Medical Doctor

NPI 1124018270 CMS profile 907353

80 Oak Hill Rd, Red Bank, NJ 07701

Open in the dashboard

General payments

$2,353

41 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$118,355

1 holding reported · through program year 2025

Through program year 2025, Steven Friedel of Red Bank, NJ is reported in the CMS Open Payments database as having received $2,353 across 41 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $118,355 across 1 holding.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 42nd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $256 5
2024 General $75 3
2023 General $317 5
2022 General $1,082 8
2021 General $177 8
2020 General $199 3
2019 General $248 9
2021 Ownership $118,355 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Steven Friedel
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Steven Friedel were reported at $256. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Steven Friedel Orthopaedic Surgery median Middle half National median
2019 $248 $644 $140–$2,844 $163
2020 $199 $312 $75–$1,860 $114
2021 $177 $520 $117–$2,495 $132
2022 $1,082 $598 $128–$2,731 $149
2023 $317 $461 $128–$2,264 $160
2024 $75 $497 $134–$2,475 $164
2025 $256 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medical Device Business Services, Inc. $1,017 7 payments
  2. DePuy Synthes Sales Inc. $444 21 payments
  3. Globus Medical, Inc. $306 4 payments
  4. Zimmer Biomet Holdings, Inc. $285 5 payments
  5. Bioventus LLC $149 1 payment
  6. Davol Inc. $74 1 payment
  7. Next Science LLC $65 1 payment
  8. Sanofi-Aventis U.S. LLC $13 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $1,554 38 payments
  2. Travel and Lodging $800 3 payments
Products named General payments · program years 2019–2025
  1. Gel-One Cross-linked Hyaluronate $285 5 payments
  2. ANTHEM $190 2 payments
  3. MONOVISC Sports Early Intervention $176 10 payments
  4. Durolane $149 1 payment
  5. MONOVISC Sports Early Intervention $143 8 payments
  6. EXPAREL $125 1 payment
  7. VAPR $109 2 payments
  8. ORTHOVISC $108 4 payments
  9. Distal Tibia Plating $94 1 payment
  10. ARISTA AH FlexiTip $74 1 payment
  11. Other $182 5 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

147

Median for Orthopedic Surgery: 203

Drug cost

$1,236

Median for Orthopedic Surgery: $1,433

Branded share of claims

44.9%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Generic 15 $380
Methylprednisolone Generic 40 $245
Acetaminophen-Codeine Acetaminophen With Codeine Brand 27 $196
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 23 $186
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 16 $136
Meloxicam Generic 11 $57
Tramadol Hcl Generic 15 $36

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 101 billing codes

Paid by Medicare

$201,899

Of which drugs: $52,000

Medicare patients

583

Average age 75

Services billed

12,745

355 women, 228 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 71%
Ischemic heart disease 34%
Diabetes 29%
Osteoporosis 19%
Depression 18%
Atrial fibrillation 17%
Cancer 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, monovisc, for intra-articular injection, per dose J7327 Office 28 46 $24,834
Hyaluronan or derivative, gel-one, for intra-articular injection, per dose J7326 Office 32 60 $24,210
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 98 1,520 $1,141
Injection, methylprednisolone acetate, 1 mg J1010 Office 89 8,680 $884
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 46 73 $385
Injection, methylprednisolone acetate, 40 mg J1030 Office 32 66 $252

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

41 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record